カテゴリー： QYResearch, 世界, 医療/バイオ

デソゲストレル錠＆エチニルエストラジオール錠のグローバル市場2023年：短時間作用型避妊薬、長時間作用型避妊薬

◆英語タイトル：Global Desogestrel and Ethinyl Estradiol Tablets Market Research Report 2023
	◆商品コード：QYR23MA8735 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2023年3月 ◆ページ数：95 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD2,900 ⇒換算￥440,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD4,350 ⇒換算￥661,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD5,800 ⇒換算￥881,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のデソゲストレル錠＆エチニルエストラジオール錠市場について調査・分析し、世界のデソゲストレル錠＆エチニルエストラジオール錠市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（短時間作用型避妊薬、長時間作用型避妊薬）、用途別セグメント分析（病院、クリニック）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Cipla、Bayer、Merck、Teva Pharmaceutical、Allergan、Pfizer、Reckitt Benckiser、Mankind Pharma、Janssen Pharmaceutical、HLL Lifecare、Mithra Pharmaceuticalsなどが含まれています。世界のデソゲストレル錠＆エチニルエストラジオール錠市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、デソゲストレル錠＆エチニルエストラジオール錠市場規模を推定する際に考慮しました。

・デソゲストレル錠＆エチニルエストラジオール錠市場の概要
- 製品の定義
- デソゲストレル錠＆エチニルエストラジオール錠のタイプ別セグメント
- 世界のデソゲストレル錠＆エチニルエストラジオール錠市場規模：タイプ別分析（短時間作用型避妊薬、長時間作用型避妊薬）
- デソゲストレル錠＆エチニルエストラジオール錠の用途別セグメント
- 世界のデソゲストレル錠＆エチニルエストラジオール錠市場規模：用途別分析（病院、クリニック）
- 世界のデソゲストレル錠＆エチニルエストラジオール錠市場規模予測（2018年-2029年）
- デソゲストレル錠＆エチニルエストラジオール錠の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- デソゲストレル錠＆エチニルエストラジオール錠市場の競争状況およびトレンド

・デソゲストレル錠＆エチニルエストラジオール錠の地域別市場規模
- 北米のデソゲストレル錠＆エチニルエストラジオール錠市場規模（2018年-2029年）
- アメリカのデソゲストレル錠＆エチニルエストラジオール錠市場規模（2018年-2029年）
- ヨーロッパのデソゲストレル錠＆エチニルエストラジオール錠市場規模（2018年-2029年）
- アジア太平洋のデソゲストレル錠＆エチニルエストラジオール錠市場規模（2018年-2029年）
- 中国のデソゲストレル錠＆エチニルエストラジオール錠市場規模（2018年-2029年）
- 日本のデソゲストレル錠＆エチニルエストラジオール錠市場規模（2018年-2029年）
- 韓国のデソゲストレル錠＆エチニルエストラジオール錠市場規模（2018年-2029年）
- インドのデソゲストレル錠＆エチニルエストラジオール錠市場規模（2018年-2029年）
- オーストラリアのデソゲストレル錠＆エチニルエストラジオール錠市場規模（2018年-2029年）
- 中南米のデソゲストレル錠＆エチニルエストラジオール錠市場規模（2018年-2029年）
- 中東・アフリカのデソゲストレル錠＆エチニルエストラジオール錠市場規模（2018年-2029年）

・タイプ別セグメント：短時間作用型避妊薬、長時間作用型避妊薬
- 世界のデソゲストレル錠＆エチニルエストラジオール錠のタイプ別販売量（2018年-2023年）
- 世界のデソゲストレル錠＆エチニルエストラジオール錠のタイプ別売上（2018年-2023年）
- 世界のデソゲストレル錠＆エチニルエストラジオール錠のタイプ別価格

・用途別セグメント：病院、クリニック
- 世界のデソゲストレル錠＆エチニルエストラジオール錠の用途別販売量（2018年-2023年）
- 世界のデソゲストレル錠＆エチニルエストラジオール錠の用途別売上（2018年-2023年）
- 世界のデソゲストレル錠＆エチニルエストラジオール錠の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Cipla、Bayer、Merck、Teva Pharmaceutical、Allergan、Pfizer、Reckitt Benckiser、Mankind Pharma、Janssen Pharmaceutical、HLL Lifecare、Mithra Pharmaceuticals

・産業チェーンと販売チャネルの分析
- デソゲストレル錠＆エチニルエストラジオール錠産業チェーン分析
- デソゲストレル錠＆エチニルエストラジオール錠の主要原材料
- デソゲストレル錠＆エチニルエストラジオール錠の販売チャネル
- デソゲストレル錠＆エチニルエストラジオール錠のディストリビューター
- デソゲストレル錠＆エチニルエストラジオール錠の主要顧客

・デソゲストレル錠＆エチニルエストラジオール錠市場ダイナミクス
- デソゲストレル錠＆エチニルエストラジオール錠の業界動向
- デソゲストレル錠＆エチニルエストラジオール錠市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Highlights
The global Desogestrel and Ethinyl Estradiol Tablets market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Desogestrel and Ethinyl Estradiol Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Desogestrel and Ethinyl Estradiol Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Desogestrel and Ethinyl Estradiol Tablets include Cipla, Bayer, Merck, Teva Pharmaceutical, Allergan, Pfizer, Reckitt Benckiser, Mankind Pharma and Janssen Pharmaceutical, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Desogestrel and Ethinyl Estradiol Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Desogestrel and Ethinyl Estradiol Tablets.
The Desogestrel and Ethinyl Estradiol Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Desogestrel and Ethinyl Estradiol Tablets market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Desogestrel and Ethinyl Estradiol Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Cipla
Bayer
Merck
Teva Pharmaceutical
Allergan
Pfizer
Reckitt Benckiser
Mankind Pharma
Janssen Pharmaceutical
HLL Lifecare
Mithra Pharmaceuticals
Segment by Type
Short-acting Contraceptives
Long-acting Contraceptives
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Desogestrel and Ethinyl Estradiol Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Desogestrel and Ethinyl Estradiol Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Desogestrel and Ethinyl Estradiol Tablets Market Overview
1.1 Product Overview and Scope of Desogestrel and Ethinyl Estradiol Tablets
1.2 Desogestrel and Ethinyl Estradiol Tablets Segment by Type
1.2.1 Global Desogestrel and Ethinyl Estradiol Tablets Market Value Comparison by Type (2023-2029)
1.2.2 Short-acting Contraceptives
1.2.3 Long-acting Contraceptives
1.3 Desogestrel and Ethinyl Estradiol Tablets Segment by Application
1.3.1 Global Desogestrel and Ethinyl Estradiol Tablets Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Desogestrel and Ethinyl Estradiol Tablets Market Size Estimates and Forecasts
1.4.1 Global Desogestrel and Ethinyl Estradiol Tablets Revenue 2018-2029
1.4.2 Global Desogestrel and Ethinyl Estradiol Tablets Sales 2018-2029
1.4.3 Global Desogestrel and Ethinyl Estradiol Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Desogestrel and Ethinyl Estradiol Tablets Market Competition by Manufacturers
2.1 Global Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Desogestrel and Ethinyl Estradiol Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Desogestrel and Ethinyl Estradiol Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Desogestrel and Ethinyl Estradiol Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Desogestrel and Ethinyl Estradiol Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Desogestrel and Ethinyl Estradiol Tablets, Product Type & Application
2.7 Desogestrel and Ethinyl Estradiol Tablets Market Competitive Situation and Trends
2.7.1 Desogestrel and Ethinyl Estradiol Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Desogestrel and Ethinyl Estradiol Tablets Players Market Share by Revenue
2.7.3 Global Desogestrel and Ethinyl Estradiol Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Desogestrel and Ethinyl Estradiol Tablets Retrospective Market Scenario by Region
3.1 Global Desogestrel and Ethinyl Estradiol Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Desogestrel and Ethinyl Estradiol Tablets Global Desogestrel and Ethinyl Estradiol Tablets Sales by Region: 2018-2029
3.2.1 Global Desogestrel and Ethinyl Estradiol Tablets Sales by Region: 2018-2023
3.2.2 Global Desogestrel and Ethinyl Estradiol Tablets Sales by Region: 2024-2029
3.3 Global Desogestrel and Ethinyl Estradiol Tablets Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Region: 2018-2029
3.3.1 Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Region: 2018-2023
3.3.2 Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Region: 2024-2029
3.4 North America Desogestrel and Ethinyl Estradiol Tablets Market Facts & Figures by Country
3.4.1 North America Desogestrel and Ethinyl Estradiol Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2018-2029)
3.4.3 North America Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Desogestrel and Ethinyl Estradiol Tablets Market Facts & Figures by Country
3.5.1 Europe Desogestrel and Ethinyl Estradiol Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2018-2029)
3.5.3 Europe Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Desogestrel and Ethinyl Estradiol Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Desogestrel and Ethinyl Estradiol Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Desogestrel and Ethinyl Estradiol Tablets Market Facts & Figures by Country
3.7.1 Latin America Desogestrel and Ethinyl Estradiol Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2018-2029)
3.7.3 Latin America Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Desogestrel and Ethinyl Estradiol Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Desogestrel and Ethinyl Estradiol Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Desogestrel and Ethinyl Estradiol Tablets Sales by Type (2018-2029)
4.1.1 Global Desogestrel and Ethinyl Estradiol Tablets Sales by Type (2018-2023)
4.1.2 Global Desogestrel and Ethinyl Estradiol Tablets Sales by Type (2024-2029)
4.1.3 Global Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Type (2018-2029)
4.2 Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Type (2018-2029)
4.2.1 Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Type (2018-2023)
4.2.2 Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Type (2024-2029)
4.2.3 Global Desogestrel and Ethinyl Estradiol Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Desogestrel and Ethinyl Estradiol Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Desogestrel and Ethinyl Estradiol Tablets Sales by Application (2018-2029)
5.1.1 Global Desogestrel and Ethinyl Estradiol Tablets Sales by Application (2018-2023)
5.1.2 Global Desogestrel and Ethinyl Estradiol Tablets Sales by Application (2024-2029)
5.1.3 Global Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Application (2018-2029)
5.2 Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Application (2018-2029)
5.2.1 Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Application (2018-2023)
5.2.2 Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Application (2024-2029)
5.2.3 Global Desogestrel and Ethinyl Estradiol Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Desogestrel and Ethinyl Estradiol Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Cipla
6.1.1 Cipla Corporation Information
6.1.2 Cipla Description and Business Overview
6.1.3 Cipla Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Cipla Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.1.5 Cipla Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bayer Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Merck Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Teva Pharmaceutical
6.4.1 Teva Pharmaceutical Corporation Information
6.4.2 Teva Pharmaceutical Description and Business Overview
6.4.3 Teva Pharmaceutical Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teva Pharmaceutical Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.4.5 Teva Pharmaceutical Recent Developments/Updates
6.5 Allergan
6.5.1 Allergan Corporation Information
6.5.2 Allergan Description and Business Overview
6.5.3 Allergan Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Allergan Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.5.5 Allergan Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Pfizer Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Reckitt Benckiser
6.6.1 Reckitt Benckiser Corporation Information
6.6.2 Reckitt Benckiser Description and Business Overview
6.6.3 Reckitt Benckiser Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Reckitt Benckiser Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.7.5 Reckitt Benckiser Recent Developments/Updates
6.8 Mankind Pharma
6.8.1 Mankind Pharma Corporation Information
6.8.2 Mankind Pharma Description and Business Overview
6.8.3 Mankind Pharma Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Mankind Pharma Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.8.5 Mankind Pharma Recent Developments/Updates
6.9 Janssen Pharmaceutical
6.9.1 Janssen Pharmaceutical Corporation Information
6.9.2 Janssen Pharmaceutical Description and Business Overview
6.9.3 Janssen Pharmaceutical Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Janssen Pharmaceutical Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.9.5 Janssen Pharmaceutical Recent Developments/Updates
6.10 HLL Lifecare
6.10.1 HLL Lifecare Corporation Information
6.10.2 HLL Lifecare Description and Business Overview
6.10.3 HLL Lifecare Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 HLL Lifecare Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.10.5 HLL Lifecare Recent Developments/Updates
6.11 Mithra Pharmaceuticals
6.11.1 Mithra Pharmaceuticals Corporation Information
6.11.2 Mithra Pharmaceuticals Desogestrel and Ethinyl Estradiol Tablets Description and Business Overview
6.11.3 Mithra Pharmaceuticals Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Mithra Pharmaceuticals Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.11.5 Mithra Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Desogestrel and Ethinyl Estradiol Tablets Industry Chain Analysis
7.2 Desogestrel and Ethinyl Estradiol Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Desogestrel and Ethinyl Estradiol Tablets Production Mode & Process
7.4 Desogestrel and Ethinyl Estradiol Tablets Sales and Marketing
7.4.1 Desogestrel and Ethinyl Estradiol Tablets Sales Channels
7.4.2 Desogestrel and Ethinyl Estradiol Tablets Distributors
7.5 Desogestrel and Ethinyl Estradiol Tablets Customers
8 Desogestrel and Ethinyl Estradiol Tablets Market Dynamics
8.1 Desogestrel and Ethinyl Estradiol Tablets Industry Trends
8.2 Desogestrel and Ethinyl Estradiol Tablets Market Drivers
8.3 Desogestrel and Ethinyl Estradiol Tablets Market Challenges
8.4 Desogestrel and Ethinyl Estradiol Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ デソゲストレル錠＆エチニルエストラジオール錠のグローバル市場2023年：短時間作用型避妊薬、長時間作用型避妊薬(Global Desogestrel and Ethinyl Estradiol Tablets Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

デソゲストレル錠＆エチニルエストラジオール錠のグローバル市場2023年：短時間作用型避妊薬、長時間作用型避妊薬

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp